HW Exclusive

HW Exclusive with Anant Bhan: Could India Have Avoided The Confusion Over Covid-19 Vaccines?

From past two days everyone is talking about the Coronavirus vaccines approved by India’s Drug Controller General of India. It was on Sunday that it gave formal approval to two vaccines one that is developed by Oxford-AstraZeneca and manufactured by Serum Institute of India. This is known as Covishield. And the other one is Covaxin. developed by Bharat Biotech in collaboration with ICMR. However, the even before the rollout, India’s vaccine drive has run into major controversy. There are many question, a lot of doubts and definitely confusion.
In this video today, we will talk about this and try and make sense of this debate. Joining me is Mr Anant Bhan. He is Global Health and Bio-ethics researcher and has worked in the sphere of Public health for many years. Let’s understand the issue from him.

#CoronavirusVaccine #Covid19 #BharatBitech #Covaxin #Covishield #SerumInstituteofIndia #OxfordAstraZeneca

Dear Readers,
As an independent media platform, we do not take advertisements from governments and corporate houses. It is you, our readers, who have supported us on our journey to do honest and unbiased journalism. Please contribute, so that we can continue to do the same in future.

Related posts